Cancer News and Research

Latest Cancer News and Research

Tower announces formation of Cancer Support Network to provide high quality of care

As part of its commitment to providing the highest quality of care to the community, Tower Hematology Oncology Medical Group has announced the formation of Tower Oncology's Cancer Support Network.

8 Feb 2011

Ability of e-cigarettes to help smokers cut down or quit still unknown

Electronic cigarettes are drawing heavy media and marketing attention, and while a new study finds that consumer interest also runs high, a companion study underscores that e-cigarettes' ability to help smokers cut down or quit is unknown.

8 Feb 2011

PDL, UCB enter definitive settlement agreement to resolve all legal patent disputes

UCB SA, on behalf of its affiliate UCB Pharma S.A., and PDL BioPharma, today jointly announced that the companies have entered into a definitive settlement agreement that resolves all legal disputes between them, including those relating to UCB's pegylated humanized antibody fragment, Cimzia, and PDL's patents known as the Queen et al. patents.

8 Feb 2011

Ansaris receives milestone payment for identification of kinase-related compound for cancer, autoimmune diseases

Ansaris announced today that it has received a milestone payment for the successful identification of a kinase-related compound under its drug discovery collaboration with Ono Pharmaceutical Co., Ltd. Ono will initiate the preclinical study of the identified compound. This collaboration between Ansaris and Ono was established to focus on the discovery of kinase-related compounds for the treatment of cancer, inflammatory and autoimmune diseases.

8 Feb 2011

Fast track rehabilitation program effective after colorectal surgery

The concept of fast track rehabilitation program has been recently introduced in colorectal surgery. It is basically a multidisciplinary perioperative care strategy for patients after resection of colorectal cancer.

8 Feb 2011

NKT, DSM sign contract to develop therapeutics based on natural killer T cells

DSM Biologics, a business unit of DSM Pharmaceutical Products, today announced the signing of a contract with NKT Therapeutics, Inc. based in Waltham, Mass, USA, the biotechnology company that focuses on developing therapeutics based on unique immune cells called natural killer T cells.

8 Feb 2011

NCI awards grant to reduce cancer-related health disparities among Latinos

A $4 million, five-year grant from the National Cancer Institute will create a Texas regional Community Networks Program Center, called Latinos Contra El Cancer, to reduce cancer-related health disparities among Texas Latinos.

8 Feb 2011

Genentech's OCEANS Phase III study of Avastin in platinum-sensitive ovarian cancer meets primary endpoint

Genentech, a member of the Roche Group, announced today that OCEANS, a Phase III study evaluating Avastin® (bevacizumab) in combination with chemotherapy (carboplatin and gemcitabine) followed by continued use of Avastin alone until disease progression in women with previously treated (recurrent), platinum-sensitive ovarian cancer, met its primary endpoint.

8 Feb 2011

New report provides insight into link between intelligence, personality traits, various health outcomes

Do smarter people live longer and better lives? Are certain personality types more prone to premature death than are others? A new report in Psychological Science in the Public Interest, a journal of the Association for Psychological Science, provides an overview of research on possible associations between intelligence and personality traits and various health outcomes.

8 Feb 2011

Dots to donate $91,086 for Cure's 'Girlfriends Giving Back' partnership program

Dots, LLC announced today that it will donate $91,086 to Susan G. Komen for the Cure to help fund ground-breaking research and life-saving community outreach projects through the "Girlfriends Giving Back" partnership program.

8 Feb 2011

Higher vitamin D levels and sun exposure linked to lower risk of multiple sclerosis

People who spend more time in the sun and those with higher vitamin D levels may be less likely to develop multiple sclerosis (MS), according to a study published in the February 8, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology. MS is a chronic disease of the brain and spinal cord, usually with recurrent flare-ups of symptoms. It is often preceded by a first episode (or event) of similar symptoms lasting days to weeks.

8 Feb 2011

EpiCept enters definitive agreements to purchase 8.9 million shares of common stock

EpiCept Corporation announced today that it has entered into definitive agreements for the purchase of approximately 8.9 million shares of its common stock at $0.80 per share, and five-year warrants to purchase up to approximately 3.6 million shares of common stock at an exercise price of $0.75 per share.

8 Feb 2011

Study on non-surgical approach for treatment of liver hydatidosis

Concerning treatment, until recently the only definitive treatment for hydatid disease had been surgery. Different surgical techniques and procedures have been carried out and even in some cases, a liver transplant has been required. Advances in drug therapy has been influenced by the introduction of albendazole and accelerated by addition of praziquantel, but this requires a long period of treatment i.e. up to a year or more, and is not effective for everyone.

8 Feb 2011

Munich research team provides promising alternative to DNA-based procedures

Defects in the genome are the cause of many diseases. Gene therapy - direct replacement of mutant genes by intact DNA copies - offers a means of correcting such defects. Now a research team based at the Medical Center of the University of Munich, and led by Privatdozent Dr. Carsten Rudolph, has taken a new approach that avoids DNA delivery.

8 Feb 2011

Researchers identify enzyme that protects against inflammation, joint destruction

A team of researchers at the University of Gothenburg, Sweden, has identified an enzyme that protects against inflammation and joint destruction. Made when the researchers blocked production of the enzyme GGTase-I in transgenic mice, this unexpected discovery could lead to the identification of new mechanisms that control the development of inflammatory disorders, as well as new medicines.

8 Feb 2011

Executive wellness a legit corporate expense

At least once a year, executives from Ciena Corp. spend a day at Johns Hopkins University getting poked and prodded as they undergo tests for a barrage of potential ailments, from anemia to prostate cancer. They

8 Feb 2011

Tufts announces public launch of Institute for Biomedical Partnerships, HUB website

Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.

8 Feb 2011

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

7 Feb 2011

PharmaMar initiates PM060184 Phase I clinical trial in patients with solid tumors

PharmaMar SA has announced the commencement of a Phase I clinical trial with PM060184 for patients with solid tumors. PM060184 is a marine-derived, synthetically-produced compound which has shown strong in vitro and in vivo antitumor activity and a favorable safety profile in preclinical toxicology studies. PM060184 is PharmaMar's sixth compound in clinical development.

7 Feb 2011

Nutritional deficiencies among indigenous populations: two studies

They find iodine deficiency for the first time among an Aboriginal population in the NT. This deficiency was previously thought to occur only in the nation’s south-eastern states. The study involved nearly 400 teenagers of aboriginal origin living in remote as well as urban areas of the Darwin Health Region, which covers 120,000 km-square of the top end of the NT.

7 Feb 2011

Cancer News and Research

Latest Cancer News and Research

Tower announces formation of Cancer Support Network to provide high quality of care

Ability of e-cigarettes to help smokers cut down or quit still unknown

PDL, UCB enter definitive settlement agreement to resolve all legal patent disputes

Ansaris receives milestone payment for identification of kinase-related compound for cancer, autoimmune diseases

Fast track rehabilitation program effective after colorectal surgery

NKT, DSM sign contract to develop therapeutics based on natural killer T cells

NCI awards grant to reduce cancer-related health disparities among Latinos

Genentech's OCEANS Phase III study of Avastin in platinum-sensitive ovarian cancer meets primary endpoint

New report provides insight into link between intelligence, personality traits, various health outcomes

Dots to donate $91,086 for Cure's 'Girlfriends Giving Back' partnership program

Higher vitamin D levels and sun exposure linked to lower risk of multiple sclerosis

EpiCept enters definitive agreements to purchase 8.9 million shares of common stock

Study on non-surgical approach for treatment of liver hydatidosis

Munich research team provides promising alternative to DNA-based procedures

Researchers identify enzyme that protects against inflammation, joint destruction

Executive wellness a legit corporate expense

Tufts announces public launch of Institute for Biomedical Partnerships, HUB website

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

PharmaMar initiates PM060184 Phase I clinical trial in patients with solid tumors

Nutritional deficiencies among indigenous populations: two studies

Understanding the DNA Damage Response in Innate Immunity eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in